ALDBT Fundamental Analysis - DBT

Fundamental Rating

ALDBT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 61 industry peers in the Electrical Equipment industry. While ALDBT seems to be doing ok healthwise, there are quite some concerns on its profitability. ALDBT does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALDBT has reported negative net income.

In the past year ALDBT has reported a negative cash flow from operations.

In the past 5 years ALDBT always reported negative net income.

In the past 5 years ALDBT always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of ALDBT (-14.55%) is worse than 81.97% of its industry peers.

ALDBT's Return On Equity of -46.17% is on the low side compared to the rest of the industry. ALDBT is outperformed by 81.97% of its industry peers.

		Industry Rank	Sector Rank
ROA	-14.55%
ROE	-46.17%
ROIC	N/A

ROA(3y)-23.56%

ROA(5y)-31%

ROE(3y)-52.67%

ROE(5y)-63.14%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALDBT has a worse Gross Margin (31.98%) than 62.30% of its industry peers.

In the last couple of years the Gross Margin of ALDBT has grown nicely.

ALDBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	31.98%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y1.62%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALDBT has been increased compared to 1 year ago.

Compared to 5 years ago, ALDBT has less shares outstanding

ALDBT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.80, we must say that ALDBT is in the distress zone and has some risk of bankruptcy.

ALDBT has a Altman-Z score of -0.80. This is amonst the worse of the industry: ALDBT underperforms 80.33% of its industry peers.

There is no outstanding debt for ALDBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-0.8

ROIC/WACCN/A

WACC3.88%

2.3 Liquidity

A Current Ratio of 0.67 indicates that ALDBT may have some problems paying its short term obligations.

With a Current ratio value of 0.67, ALDBT is not doing good in the industry: 93.44% of the companies in the same industry are doing better.

A Quick Ratio of 0.41 indicates that ALDBT may have some problems paying its short term obligations.

ALDBT has a Quick ratio of 0.41. This is amonst the worse of the industry: ALDBT underperforms 96.72% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.67
Quick Ratio	0.41

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.55% over the past year.

Looking at the last year, ALDBT shows a very negative growth in Revenue. The Revenue has decreased by -18.47% in the last year.

Measured over the past years, ALDBT shows a small growth in Revenue. The Revenue has been growing by 1.98% on average per year.

EPS 1Y (TTM)87.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3.08%

Revenue 1Y (TTM)-18.47%

Revenue growth 3Y32.91%

Revenue growth 5Y1.98%

Sales Q2Q%-29.93%

3.2 Future

ALDBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.42% yearly.

The Revenue is expected to decrease by -90.45% on average over the next years. This is quite bad

EPS Next Y28.13%

EPS Next 2Y20.08%

EPS Next 3Y24.42%

EPS Next 5YN/A

Revenue Next Year25.09%

Revenue Next 2Y25.88%

Revenue Next 3Y-90.45%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALDBT. In the last year negative earnings were reported.

Also next year ALDBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALDBT's earnings are expected to grow with 24.42% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y20.08%

EPS Next 3Y24.42%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALDBT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DBT

EPA:ALDBT (11/18/2025, 7:00:00 PM)

0.0392

+0 (+5.38%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.23%

Inst Owner ChangeN/A

Ins Owners0.08%

Ins Owner ChangeN/A

Market Cap196.78K

Revenue(TTM)8.53M

Net Income(TTM)-4.62M

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.02
P/FCF	N/A
P/OCF	N/A
P/B	0.02
P/tB	0.03
EV/EBITDA	N/A

EPS(TTM)-0.71

EYN/A

EPS(NY)-3.86

Fwd EYN/A

FCF(TTM)-2.23

FCFYN/A

OCF(TTM)-1.4

OCFYN/A

SpS1.7

BVpS2

TBVpS1.36

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.55%
ROE	-46.17%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	31.98%
FCFM	N/A

ROA(3y)-23.56%

ROA(5y)-31%

ROE(3y)-52.67%

ROE(5y)-63.14%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y1.62%

F-Score3

Asset Turnover0.27

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	259.76%
Cap/Sales	48.8%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.67
Quick Ratio	0.41
Altman-Z	-0.8

F-Score3

WACC3.88%

ROIC/WACCN/A

Cap/Depr(3y)433.24%

Cap/Depr(5y)302.25%

Cap/Sales(3y)51%

Cap/Sales(5y)37.98%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)87.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3.08%

EPS Next Y28.13%

EPS Next 2Y20.08%

EPS Next 3Y24.42%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.47%

Revenue growth 3Y32.91%

Revenue growth 5Y1.98%

Sales Q2Q%-29.93%

Revenue Next Year25.09%

Revenue Next 2Y25.88%

Revenue Next 3Y-90.45%

Revenue Next 5YN/A

EBIT growth 1Y19.68%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year39.41%

EBIT Next 3Y26.01%

EBIT Next 5YN/A

FCF growth 1Y-16.03%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-39.36%

OCF growth 3YN/A

OCF growth 5YN/A

DBT / ALDBT.PA FAQ

Can you provide the ChartMill fundamental rating for DBT?

ChartMill assigns a fundamental rating of 2 / 10 to ALDBT.PA.

What is the valuation status for ALDBT stock?

ChartMill assigns a valuation rating of 1 / 10 to DBT (ALDBT.PA). This can be considered as Overvalued.

What is the profitability of ALDBT stock?

DBT (ALDBT.PA) has a profitability rating of 1 / 10.

What is the earnings growth outlook for DBT?

The Earnings per Share (EPS) of DBT (ALDBT.PA) is expected to grow by 28.13% in the next year.

DBT (ALDBT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DBT / ALDBT.PA FAQ

Can you provide the ChartMill fundamental rating for DBT?

What is the valuation status for ALDBT stock?

What is the profitability of ALDBT stock?

What is the earnings growth outlook for DBT?